Market by Display, Technology, Type, End-user, and Country Outlook | Forecast 2022-2028
As per Triton’s research report, the Asia-Pacific cardiovascular ultrasound market is anticipated to grow with a CAGR of 6.83% in the forecasting years from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in this region include:
• South Korea
• China
• India
• ASEAN Countries
• Japan
• Australia & New
Zealand
• Rest of Asia-Pacific
China is the leading market in the region and
holds the largest market share. With the increased preference for minimally invasive surgeries in the
region, portable ultrasound machines are witnessing high demand. However,
setting up the whole echocardiography infrastructure is a cost-intensive
procedure, which is likely to hinder market growth.
In 2019, cardiovascular disease (CVD) was responsible for nearly 47% of
total deaths in China, accounting for 2 out of every 5 deaths. CVD deaths in
the country were closely related to the presence of an aging population. With
the number of people affected by CVD increasing, several major companies like
Mindray are offering products for imaging, ultrasound, radiology, patient
monitoring, and other applications. This is expected to foster the considered
market’s growth in the coming years.
The Australian population has a high prevalence
rate of cardiovascular diseases. Coronary heart disease (CHD) is the single
leading cause of disease burden death, and accounts for 11% of total deaths
(nearly 42% of all CVD deaths). The country’s government launched the
Cardiovascular Health Mission in 2019, and announced it would invest $220
million in research efforts to tackle CVDs and stroke. Such measures are
expected to foster the demand for cardiovascular ultrasound systems in the
country.
2D ultrasound is the most commonly utilized technology in cardiovascular
ultrasound. This 2D or two-dimensional technology is the foundation of echo
imaging and allows to have a real-time view of moving structures in a
cross-section of the heart. It detects any kind of abnormal anatomy or movement
in the heart structure, accurately guiding doctors in the process of diagnosis.
The report assesses the market based on
technology, display, type, and end-user. Here, the technology segment comprises 2D,
3D/4D, and Doppler.
Philips Healthcare, Telemed Ultrasound Medical
Systems, Leltek Inc, Samsung Medison Co Ltd, Clarius, Viatom Technology Co,
Lanmage, and Zoncare are some acclaimed names in the cardiovascular ultrasound
market.
Shenzhen Lanmage Medical Technology Co Ltd (Lanmage) is a leading
company providing medical imaging solutions. It operates in segments like
Ultrasound, Radiography, and Cloud Imaging. The C6 Portable Color Doppler
Ultrasound System is a high-speed signal processing platform that greatly
enhances imaging efficiency.
Equipped with powerful functionalities, it is used in cardiac, vascular,
neuromuscular gynecological, abdominal, and small organ scanning applications.
Founded in 2015, Lanmage has expanded its business in other regions within a
short time. It is headquartered in Shenzhen, China. With its high annual sales,
the company steadily ranks in the top three digital radiology equipment
suppliers in the country.
Key deliverables of the
report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the cardiovascular ultrasound market revenue growth in Asia-Pacific and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
●
A wide-ranging study of factors that will challenge the
Asia-Pacific cardiovascular ultrasound market’s growth during the upcoming
years
Want to get specific insights? Our team of analysts can customize this
report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY
INSIGHTS
2.2.1. EMERGENCE
OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN
IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. PRODUCT
LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET
DRIVERS
2.10.1. INCREASE
IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS
IN TECHNOLOGY
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AMONG PATIENTS
2.11.2. NEED
TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET
OPPORTUNITIES
2.12.1. RAPID
EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. GROWING
CARDIOVASCULAR ULTRASOUND MARKET IN THE ASIA-PACIFIC REGION
2.12.3. RAPID
GROWTH OF FETAL ECHOCARDIOGRAPHY
3. ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK
AND WHITE
3.2. COLORED
4. ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC
ECHOCARDIOGRAPHY
5.2. FETAL
ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL
ECHOCARDIOGRAPHY
5.4. OTHER
TYPES
6. ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC
CENTERS
6.3. AMBULATORY
CARE CENTERS
6.4. OTHER
END-USERS
7. ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH
KOREA
7.5. ASEAN
COUNTRIES
7.6. AUSTRALIA
& NEW ZEALAND
7.7. REST
OF ASIA-PACIFIC
8. COMPETITIVE
LANDSCAPE
8.1. GE
HEALTHCARE
8.2. PHILIPS
HEALTHCARE
8.3. SIEMENS
HEALTHINEERS
8.4. CANON
MEDICAL CORP
8.5. FUJIFILM
HOLDINGS CORPORATION
8.6. SAMSUNG
MEDISON CO LTD
8.7. ESAOTE
S.P.A.
8.8. MINDRAY
MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM
TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI
MEDICAL
8.12. ZONCARE
8.13. LELTEK
INC
8.14. TELEMED
ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT
LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028
(IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $
MILLION)
FIGURE 14: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY,
2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $
MILLION)
FIGURE 19: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $
MILLION)
FIGURE 20: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: CHINA
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: JAPAN
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: INDIA
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH KOREA
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: ASEAN COUNTRIES
CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: AUSTRALIA & NEW
ZEALAND CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: REST OF
ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)